Www.adi2018 - Alzheimer's Disease International (ADI)

33rd International Conference of Alzheimer's Disease International

26 ? 29 July 2018, Chicago, USA



@ADIConference @AlzDisInt #ADI2018 Alzheimer's Disease International

I'MANNE

NOT "ANNE WITH

ALZHEIMER'S"

I WON'T LET EARLY TO MILD ALZHEIMER'S DISEASE DEFINE WHO I AM.

So I am choosing to do something about it. That's why I decided to learn about the TANGO Study: a clinical research study evaluating an investigational drug for people with early to mild Alzheimer's disease. If you are between 50 to 80 years of age (inclusive), you may be eligible to participate.

To see if you may be eligible to participate, please speak with a member of our study staff or visit us at .

All eligible study participants will receive:

Comprehensive study-related health evaluations and assessments Investigational drug or placebo, visits, and care

Travel assistance to and from study visits

Be more than just a patient ? be a partner.

M-AP-US-00027

Please Join Us for a Lunch Program

THINKING GLOBALLY ABOUT ALZHEIMER'S DISEASE

Jeffrey Cummings, MD, ScD

Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, NV

Jianping Jia, MD, PhD

Xuan Wu Hospital Capital Medical University Beijing, China

Soeren Mattke, MD, DSc University of Southern California Los Angeles, CA

Wendy Weidner

Alzheimer's Disease International London, UK

Saturday, July 28, 2018 12:45 pm - 1:45 pm

McCormick Place, Room 196b, Chicago, Illinois West Wing

Visit us at booth #200 at ADI 2018

Join Eisai for an interactive symposium titled, "Thinking Globally About Alzheimer's Disease". A diverse panel of experts will discuss the global nature of clinical trials and evaluate global readiness to screen, diagnose, and treat Alzheimer's disease as the paradigm shifts towards initiating treatment earlier in the disease course.

Vermont law prohibits, Minnesota law restricts, and Department of Veterans Affairs and Department of Defense policy prohibits Eisai from offering meals at speaker events to certain health care professionals. If you are licensed in either of those states, or employed by either agency, Eisai regrets that due to these restrictions, we will not be able to offer a meal in conjunction with this event. The state of New Jersey limits the value of meals that NJ licensed prescribers may accept to $15. Eisai is required by Massachusetts, Vermont, Washington, DC, and the Federal Physician Payment Sunshine Act, and European Federation of Pharmaceutical Industries and Associations (EFPIA) codes to disclose certain value transfers, eg, meals, provided to certain health care professionals. If you have questions regarding how Eisai tracks and reports this information, please contact Eisai at 1-855-643-4328. This invitation is intended for the recipient only. Spouses or other guests are not permitted to attend Speaker Programs. This promotional event is sponsored by Eisai, and the speaker is a paid consultant presenting on behalf of Eisai. Eisai complies with all relevant laws, regulations, and codes of conduct.

? 2018 Eisai Inc. All rights reserved. July 2018 PIPN-M2037

CONTENTS



CONTENTS

Welcome from Mayor of Chicago Welcome from Chair of Alzheimer's Disease International (ADI) Introduction from Alzheimer's Disease International (ADI) About Alzheimer's Disease International (ADI) Conference committees Acknowledgements Exhibition Exhibition floor plan Plenary speakers Scientific programme at a glance ? Thursday 26 July 2018 Scientific programme at a glance ? Friday 27 July 2018 Scientific programme at a glance ? Saturday 28 July 2018 Scientific programme at a glance ? Sunday 29 July 2018 Workshops and symposiums Venue floorplan Poster board layout Scientific programme ? Thursday 26 July 2018 Scientific programme ? Friday 27 July 2018 Scientific programme ? Saturday 28 July 2018 Scientific programme ? Sunday 29 July 2018 Poster presentations General information Travel and local information Social events and activities Authors' index

4

5

6

7

8

9

10

11

3

12-20

21

22

23

24

25-29

30-31

32

33

34-41

42-48

49-52

53-67

68-70

70

71

72-83

@ADIConference @AlzDisInt #ADI2018

WELCOME LETTERS

33rd International Conference of Alzheimer's Disease International

26 ? 29 July 2018, Chicago, USA

WELCOME LETTER FROM MAYOR OF CHICAGO

4

Alzheimer's Disease International

WELCOME LETTERS



WELCOME LETTER FROM ALZHEIMER'S DISEASE INTERNATIONAL

Glenn Rees AM Chair, Alzheimer's Disease International

Dear Friends

I am delighted to have this opportunity to welcome you to the 33rd International Conference of Alzheimer's Disease International in Chicago and to thank the Alzheimer's Association for the support they have given to ADI in organising the conference.

Holding the conference in the USA is a recognition of the extraordinary contribution America

has made to the funding of dementia research to better understand the causes of dementia, the

5

development of new clinical treatments and the provision of better quality care.

The adoption of the `Global action plan on the public health response to dementia' by all Members of the World Health Organisation in May last year gives an added impetus to share knowledge and to urge governments worldwide to implement funded national dementia plans that result in a better quality of life for millions of people with dementia and their families. The Plan has set seven priorities and targets for action between now and 2025 and requires the active monitoring of the targets, including reporting by Member States. This conference will capture the unique opportunity we have as a global community to act together to increase the awareness of dementia and to improve the care and treatment of dementia.

This century has started well in getting dementia onto the public health agenda and increasing awareness of the social and economic impact of dementia. The strength of ADI has been to address the complex and interdependent health and social issues in dementia policy by bringing together people with dementia and their care partners with researchers and health and social workers. It is important to share a common vision for the future and to identify the most effective strategies to achieve a timely diagnosis, post diagnostic support and dementia friendly communities. I hope you will find the programme of the conference inspiring and instructive with the right amount of innovation.

Increasing awareness and reducing stigma is at the heart of the work of ADI. `Every Three Seconds' will premiere at the conference. Drawing upon ITN's expertise in storytelling and the knowledge of worldwide leaders in dementia care, science and innovation, the news-style piece will be an extraordinary opportunity to reduce the stigma attached to dementia worldwide.

I acknowledge too the importance of the President of Costa Rica and the Queen of Spain lending their support to the work of ADI and increasing the awareness of dementia.

I am confident that the staff of ADI and the Alzheimer's Association will do everything they can to make us all feel welcome.

My best wishes for a great conference.

Glenn Rees AM Chair, Alzheimer's Disease International

@ADIConference @AlzDisInt #ADI2018

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download